|Other names||5-methoxy DBT; N,N-Dibutyl-5-methoxy-1H-indole-3-ethanamine|
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||302.462 g·mol−1|
|3D model (JSmol)|
5-MeO-DBT (5-Methoxy-N,N-dibutyltryptamine, 5-MeO-BET) is a rare substituted tryptamine derivative, which is thought to be a psychoactive substance and was identified in a designer drug sample by a forensic laboratory in Slovenia in March 2021, although only analytical studies have been conducted and no pharmacological data is available. It is nevertheless controlled under drug analogue legislation in a number of jurisdictions.